However, unlike CD8+ T cells, γδ T cells can detect cancer cells by engaging the T cell (TCR) or natural killer (NK) receptors without any obligate requirement for cognate cancer neoantigens presented on self-major histocompatibility complex (MHC)15. This evidence concerns the gene CD8A and cancer.